Metabolism of droloxifene in the CD-1 mouse, Fischer-344 rat and Cynomolgus monkey

Xenobiotica

Volumn 28, Issue 2, 1998, Pages 153-166

  O'Donnell, J P ^a   Khosla, N B ^a   Dalvie, D K ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CARBON 14; CYTOCHROME P450; DROLOXIFENE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; GLUCURONIDATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ADMINISTRATION, ORAL; ANIMALS; BILE; ESTROGEN ANTAGONISTS; FECES; GLUCURONATES; MACACA FASCICULARIS; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; RATS; RATS, INBRED F344; TAMOXIFEN;

ANIMALIA; MACACA FASCICULARIS;

EID: 0031939442     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239650     Document Type: Article

References (16)

1. BEVAN, D. R. and SADLER, V. M., 1992, Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo[a]pyrene. Carcinogenesis, 13, 403-407.
2. DIXON, R., HSIAO, J., HSU, H.-B., SMULKOWSKI, M., CHAN, T.-M., PRAMANIK, B. and MORTON, J., 1989, Isolation of a novel morphinan 3-O-diglucuronide metabolite from dog. Pharmaceutical Research, 6, 28-32.
3. FOUDA, H. G., AVERY, M. and NAVETTA, K., 1993, Simultaneous hplc-radioactivity and mass spectrometry monitoring. A drug metabolism application. Paper presented at the American Society of Mass Spectrometry Conference, 29 May, San Francisco, CA.
4. GRILL, H. J. and POLLOW, K., 1991, Pharmacokinetics of droloxifene and its metabolites in breast cancer patients. American Journal of Clinical Oncology, 14 (suppl. 2), s21-29.
5. HAPLIN, R. A., ULM, E. H., TILL, A. E., KARI, P. H., VYAS, K. P., HUNNINGHAKE, D. B. and DUGGAN, D. E., 1993, Biotransformation of Lovastatin. Drug Metabolism and Disposition, 21, 1003-1011.
6. HILL, M. J., 1995, Carbohydrate metabolism. In Role of Gut Microflora in Human Toxicology and Pharmacology, edited by M. J. Hill (London: Taylor & Francis), pp. 95-104.
7. JORDAN, V. C., 1995, Alternate antiestrogens and approaches to the prevention of breast cancer. Journal of Cellular Biochemistry, 22 (suppl.), 51-57.
8. KE, H. Z., SIMMONS, H. A., PIRIE, C. M., CRAWFORD, D. T. and THOMPSON, D. D., 1995, Droloxifene, a new antiestrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology, 136, 2435-2441.
9. LÖSER, R., SEIBEL, K., ROSS, W. and EPPENBERGER, U., 1985, In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen. European Journal of Cancer and Clinical Oncology, 21, 985-990.
10. POON, G. K., CHUI, Y. C., MCCAGUE, R., LONNING, P. E., FENG, R., ROWLANDS, M. G. and JARMAN, M., 1993, Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients. Drug Metabolism and Disposition, 21, 1119-1124.
11. ROSS, W., OEZE, L., LÖSER, R. and EPPENBERGER, U., 1983, Antiestrogenic action of 3-hydroxytamoxifen in human breast cancer cell line MCF-7. Journal of the National Cancer Institute, 71, 55-59.
12. SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451-523.
13. STRAUB, K. M., RUDEWICZ, P. and GRAVIE, C., 1987, Metabolic mapping of drugs: rapid screening techniques for xenobiotic metabolites with MS/MS techniques. Xenobiotica, 17, 413-422.
14. TANAKA, Y., SEKIGUCHI, M., SAWAMOTO, T., HATA, T., ESUMI, Y., SUGAI, S. and NINOMIYA, S., 1994, Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients. European Journal of Drug Metabolism and Pharmacokinetics, 19, 47-58.
15. TESTA, B., 1995, Carbon oxidations oxidised by cytochrome P450. In Biochemistry of Redox Reactions, edited by B. Testa and J. Caldwell (London: Academic), pp. 122-163.
16. VRBANAC, J. J., O'LEARY, I. A. and BACZYNSKY, J., 1992, Utility of parent-neutral loss scan screening technique : partial characterization of urinary metabolites of U-78875 in monkey urine. Biological Mass Spectrometry, 21, 517-522.